Center for Behavioral Health Statistics and Quality. 2020 National survey on drug use and health: detailed tables. Rockville: Substance Abuse and Mental Health Services Administration; 2020.
DiFranza J, Savageau J, Rigotti N, Fletcher K, Ockene J, McNeill A, et al. Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tob Control. 2002;11(3):228–35.
Article CAS PubMed PubMed Central Google Scholar
Thorner ED, Jaszyna-Gasior M, Epstein DH, Moolchan ET. Progression to daily smoking: is there a gender difference among cessation treatment seekers? Subst Use Misuse. 2007;42(5):829–35.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking—50 years of progress: a report of the surgeon general (Reports of the Surgeon General). Atlanta: Centers for Disease Control and Prevention (US); 2014.
Perkins KA, Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res. 2008;10(7):1245–51.
Article CAS PubMed Google Scholar
Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA. Sex/gender differences in smoking cessation: a review. Prev Med. 2016;92:135–40.
Article PubMed PubMed Central Google Scholar
Markou A. Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3159–68.
Article CAS PubMed PubMed Central Google Scholar
Willing J, Wagner CK. Progesterone receptor expression in the developing mesocortical dopamine pathway: importance for complex cognitive behavior in adulthood. Neuroendocrinology. 2016;103(3–4):207–22.
Article CAS PubMed Google Scholar
Vashchinkina E, Manner AK, Vekovischeva O, den Hollander B, Uusi-Oukari M, Aitta-aho T, et al. Neurosteroid agonist at GABA a receptor induces persistent neuroplasticity in VTA dopamine neurons. Neuropsychopharmacology. 2014;39(3):727–37.
Article CAS PubMed Google Scholar
Bali A, Jaggi AS. Multifunctional aspects of allopregnanolone in stress and related disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:64–78.
Article CAS PubMed Google Scholar
Anker JJ, Carroll ME. The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research. Neurosci Biobehav Rev. 2010;35(2):315–33.
Article CAS PubMed PubMed Central Google Scholar
Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol. 2010;18(6):451–61.
Article CAS PubMed PubMed Central Google Scholar
Frye CA, Rhodes ME. Infusions of 3α,5α-THP to the VTA enhance exploratory, anti-anxiety, social, and sexual behavior and increase levels of 3α,5α-THP in midbrain, hippocampus, diencephalon, and cortex of female rats. Behav Brain Res. 2008;187(1):88–99.
Article CAS PubMed Google Scholar
Fish EW, Whitman BJ, DiBerto JF, Robinson JE, Morrow AL, Malanga CJ. Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice. Psychopharmacology. 2014;231(17):3415–23.
Article CAS PubMed PubMed Central Google Scholar
Peart DR, Andrade AK, Logan CN, Knackstedt LA, Murray JE. Regulation of cocaine-related behaviours by estrogen and progesterone. Neurosci Biobehav Rev. 2022;135:104584.
Article CAS PubMed Google Scholar
Schüle C, Nothdurfter C, Rupprecht R. The role of allopregnanolone in depression and anxiety. Prog Neurobiol. 2014;113:79–87.
Milivojevic V, Fox HC, Sofuoglu M, Covault J, Sinha R. Effects of progesterone stimulated allopregnanolone on craving and stress response in cocaine dependent men and women. Psychoneuroendocrinology. 2016;65:44–53.
Article CAS PubMed Google Scholar
Parks EE, Logan S, Yeganeh A, Farley JA, Owen DB, Sonntag WE. Interleukin 6 reduces allopregnanolone synthesis in the brain and contributes to age-related cognitive decline in mice. J Lipid Res. 2020;61(10):1308–19.
Article CAS PubMed PubMed Central Google Scholar
Picciotto MR, Caldarone BJ, King SL, Zachariou V. Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology. 2000;22(5):451–65.
Article CAS PubMed Google Scholar
Schwarzer C, Berresheim U, Pirker S, Wieselthaler A, Fuchs K, Sieghart W, et al. Distribution of the major ?-aminobutyric acid A receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. J Comp Neurol. 2001;433(4):526–49.
Article CAS PubMed Google Scholar
Sharp BM, Jiang Q, Simeone X, Scholze P. Allosteric modulation of GABAA receptors in rat basolateral amygdala blocks stress-enhanced reacquisition of nicotine self-administration. ACS Pharmacol Transl Sci. 2020;3(6):1158–64.
Article CAS PubMed PubMed Central Google Scholar
Paradiso K, Sabey K, Evers AS, Zorumski CF, Covey DF, Steinbach JH. Steroid Inhibition of rat neuronal nicotinic α4β2 receptors expressed in HEK 293 cells. Mol Pharmacol. 2000;58(2):341–51.
Article CAS PubMed Google Scholar
Bullock AE, Clark AL, Grady SR, Robinson SF, Slobe BS, Marks MJ, et al. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem. 2002;68(6):2412–23.
Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction. 2008;103(5):809–21.
Article PubMed PubMed Central Google Scholar
Mazure CM, Toll B, McKee SA, Wu R, O’Malley SS. Menstrual cycle phase at quit date and smoking abstinence at six weeks in an open label trial of bupropion. Drug Alcohol Depend. 2011;114(1):68–72.
Franklin TR, Jagannathan K, Ketcherside A, Spilka N, Wetherill RR. Menstrual cycle phase modulates responses to smoking cues in the putamen: preliminary evidence for a novel target. Drug Alcohol Depend. 2019;198:100–4.
Article PubMed PubMed Central Google Scholar
Allen A, Tosun N, Carlson S, Allen S. Postpartum changes in mood and smoking-related symptomatology: an ecological momentary assessment investigation. Nicotine Tob Res. 2018;20(6):681–9.
Forray A, Gilstad-Hayden K, Suppies C, Bogen D, Sofuoglu M, Yonkers KA. Progesterone for smoking relapse prevention following delivery: a pilot, randomized, double-blind study. Psychoneuroendocrinology. 2017;86:96–103.
Article CAS PubMed PubMed Central Google Scholar
Sofuoglu M, Babb DA, Hatsukami DK. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Behav. 2001;69(1–2):299–304.
Article CAS PubMed Google Scholar
Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 2011;36(1):123–32.
Article CAS PubMed Google Scholar
Allen A, Petersen A, Harrison K, Nair U, Allen S. Effect of exogenous progesterone administration on smoking topography. Addict Behav. 2021;112:106570.
Sofuoglu M, Mitchell E, Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol Clin Exp. 2009;24(7):559–64.
Tosun NL, Fieberg AM, Eberly LE, Harrison KA, Tipp AR, Allen AM, et al. Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial. Addiction. 2019;114(10):1800–13.
Article PubMed PubMed Central Google Scholar
Novick AM, Duffy KA, Johnson RL, Sammel MD, Cao W, Strasser AA, et al. Progesterone increases nicotine withdrawal and anxiety in male but not female smokers during brief abstinence. Nicotine Tob Res. 2022. https://doi.org/10.1093/ntr/ntac146.
Anker JJ, Holtz NA, Zlebnik N, Carroll ME. Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats. Psychopharmacology. 2009;203(1):63–72.
Article CAS PubMed Google Scholar
Anker JJ, Carroll ME. Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug Alcohol Depend. 2010;107(2):264–7.
Article CAS PubMed Google Scholar
Evans SM, Foltin RW. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology. 2006;31(3):659–74.
留言 (0)